Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11899)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2021 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tonini V, Zanni M. Pancreatic cancer in 2021: What you need to know to win. World J Gastroenterol 2021; 27(35): 5851-5889 [PMID: 34629806 DOI: 10.3748/wjg.v27.i35.5851] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v27/i35/5851.htm |
| Number | Citing Articles |
| 1 |
Yuanyuan Wei, Ahmad Taha Khalaf, Cao Rui, Samiah Yasmin Abdul Kadir, Jamaludin Zainol, Zahraa Oglah. The Emergence of TRP Channels Interactome as a Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma. Biomedicines 2023; 11(4): 1164 doi: 10.3390/biomedicines11041164
|
| 2 |
Ammar A. Javed, Omar Mahmud, Asad Saulat Fatimi, Alyssar Habib, Mahip Grewal, Jin He, Christopher L. Wolfgang, Marc G. Besselink. Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology 2024; 31(7): 4673 doi: 10.1245/s10434-024-15281-1
|
| 3 |
Jing Wang, Liping Zheng, Chundong Hu, Demiao Kong, Zhongcheng Zhou, Bin Wu, Shaohan Wu, Famin Fei, Yiyu Shen. CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein. Cellular Signalling 2023; 107: 110661 doi: 10.1016/j.cellsig.2023.110661
|
| 4 |
Chris T. P. Do, Jack Y. Prochnau, Angel Dominguez, Pei Wang, Manjeet K. Rao. The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects. Biomedicines 2024; 12(9): 1979 doi: 10.3390/biomedicines12091979
|
| 5 |
Guoxiao Zhang, Bo Li, Xiaoyi Yin, Suizhi Gao, Shuo Shen, Huan Wang, Xiaohan Shi, Wuchao Liu, Kailian Zheng, Wei Jing, Yijie Zhang, Tianlin He, Gang Li, Xiangui Hu, Shiwei Guo, Gang Jin. Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases. International Journal of Surgery 2022; 104: 106786 doi: 10.1016/j.ijsu.2022.106786
|
| 6 |
Jesse Stondell, Christine Shieh, Bao Sean Nguyen, Alex Zhornitskiy, Joane A. P. Wilson. Geriatric Medicine. 2024; : 543 doi: 10.1007/978-3-030-74720-6_54
|
| 7 |
Mengying Zhu, Feng Luo, Bin Xu, Jian Xu. Research Progress of Neural Invasion in Pancreatic Cancer. Current Cancer Drug Targets 2024; 24(4): 397 doi: 10.2174/1568009623666230817105221
|
| 8 |
Wei Zhang, Shilong Han, Yifeng Yuan, Minjie Xu, Anle Ding, Maoquan Li. FTO Knockdown-Mediated Maturation of miR-383-5p Inhibits Malignant Advancement of Pancreatic Cancer by Targeting ITGA3. Biochemical Genetics 2024; 62(4): 2652 doi: 10.1007/s10528-023-10560-0
|
| 9 |
Kush Savsani, Sivanesan Dakshanamurthy. Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma. Diseases 2024; 12(7): 149 doi: 10.3390/diseases12070149
|
| 10 |
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Mariana dos Santos Calmon, Gabriel Lima Correa Santos, Gabriel Reis Rocha, Fabrício Freire de Melo. New avenues for the treatment of immunotherapy-resistant pancreatic cancer. World Journal of Gastrointestinal Oncology 2024; 16(4): 1134-1153 doi: 10.4251/wjgo.v16.i4.1134
|
| 11 |
Ahmet Cihangir EMRAL, Gülçin TÜRKMEN SARIYILDIZ, Gökay ÇETİNKAYA, Mustafa KEREM. EFFECT OF COVID 19 PANDEMIC ON PANCREATIC CANCER SURGERY. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 2024; 56(3): 164 doi: 10.20492/aeahtd.1351744
|
| 12 |
Federica Foglietta, Patrizia Panzanelli, Riccardo Pizzo, Marta Giacone, Carlo Della Pepa, Gianni Durando, Loredana Serpe, Roberto Canaparo. Evaluation of the cytotoxic and immunomodulatory effects of sonodynamic therapy in human pancreatic cancer spheroids. Journal of Photochemistry and Photobiology B: Biology 2024; 251: 112842 doi: 10.1016/j.jphotobiol.2024.112842
|
| 13 |
Albert W. Girotti, Jonathan F. Fahey, Witold Korytowski. Role of nitric oxide in hyper-aggressiveness of tumor cells that survive various anti-cancer therapies. Critical Reviews in Oncology/Hematology 2022; 179: 103805 doi: 10.1016/j.critrevonc.2022.103805
|
| 14 |
Humaid O. Al-Shamsi, Faryal Iqbal, Neil A. Nijhawan, Hampig R. Kourie, Nadia Abdelwahed, Ibrahim H. Abu-Gheida, Basil Ammori. Cancer Care in the United Arab Emirates. 2024; : 473 doi: 10.1007/978-981-99-6794-0_29
|
| 15 |
Yan Zhang, Xiaomin Lu, Haoming Ji, Liangfeng Zheng, Guodong Chen, Ye Qian, Weiguo Li. Effects of Deep Hyperthermia Combined with Intraperitoneal Chemotherapy on Liver-Kidney Function, Immune Function, and Long-Term Survival in Patients with Abdominal Metastases. Emergency Medicine International 2023; 2023: 1 doi: 10.1155/2023/5878402
|
| 16 |
Mohammed A El-Nady, Khalid A Ead, Mustafa A Haridy, Nour Shaheen, Abdulqadir J Nashwan, Saad R Abdelwahid, Mohammed F Mohammed, Omran Mohamed, Safwat S Sawy, Emad Abdelrazzak, Amro M Hassan. Role of Endoscopic Ultrasound in Staging and Vascular Assessment of Pancreatic Cancer. Cureus 2024; doi: 10.7759/cureus.53988
|
| 17 |
Ramya Devi KT, Dharshene Karthick, Kirtikesav Salem Saravanaraj, M. K. Jaganathan, Suvankar Ghorai, Sanjana Prakash Hemdev. The Roles of MicroRNA in Pancreatic Cancer Progression. Cancer Investigation 2022; 40(8): 700 doi: 10.1080/07357907.2022.2057526
|
| 18 |
Aleksander M. Bogdanski, Anke M. Onnekink, Akin Inderson, Bas Boekestijn, Bert A. Bonsing, Hans F.A. Vasen, Jeanin E. van Hooft, Jurjen J. Boonstra, J. Sven D. Mieog, Martin N.J.M. Wasser, Shirin Feshtali, Thomas P. Potjer, Derk C.F. Klatte, Monique E. van Leerdam. The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. Pancreas 2024; 53(7): e566 doi: 10.1097/MPA.0000000000002335
|
| 19 |
Soumaya Menadi, Burak Kucuk, Ercan Cacan. Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis. Biochemical Genetics 2024; 62(4): 2721 doi: 10.1007/s10528-023-10577-5
|
| 20 |
Robert Mazur, Jan Trna. Principles of Palliative and Supportive Care in Pancreatic Cancer: A Review. Biomedicines 2023; 11(10): 2690 doi: 10.3390/biomedicines11102690
|
| 21 |
Marcin Cholewa, Julia Wójcik, Maciej Kuca, Karolina Jaglarz, Maksymilian Janeczek, Karolina Kinga Kantor, Julia Plewniok, Wiktoria Maria Szymańska, Kacper Wojciech Pamuła, Maria Partyka. Pancreatic cancer – challenge for modern medicine. Polish Journal of Public Health 2024; 134: 89 doi: 10.12923/2083-4829/2024-0019
|
| 22 |
Huaqing Shi, Zhou Chen, Shi Dong, Ru He, Yan Du, Zishun Qin, Wence Zhou. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02362-2
|
| 23 |
Ahmad Taha Khalaf, Yuanyuan Wei, Samiah Yasmin Abdul Kadir, Jamaludin Zainol, Zahraa Oglah. TRP Channels Interactome in Pancreatic Ductal Adenocarcinoma: A Potential Therapeutic Target. The 2nd International Electronic Conference on Biomedicines 2023; : 9 doi: 10.3390/ECB2023-14133
|
| 24 |
Jesse Stondell, Christine Shieh, Bao Sean Nguyen, Alex Zhornitskiy, Joane A. P. Wilson. Geriatric Medicine. 2023; : 1 doi: 10.1007/978-3-030-01782-8_54-1
|
| 25 |
Tian Deng, Yingzhi Deng, Shih-Ting Tsao, Qinghui Xiong, Yue Yao, Cuicui Liu, Ming yuan Gu, Fei Huang, Haiying Wang. Rapidly-manufactured CD276 CAR-T cells exhibit enhanced persistence and efficacy in pancreatic cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05462-7
|
| 26 |
Lina Zheng, Hailiang Liu. Prognostic association between NLRP3 inflammasome expression level and operable pancreatic adenocarcinoma. The International Journal of Biological Markers 2022; 37(3): 314 doi: 10.1177/03936155221096690
|
| 27 |
Shamsher A. Pasha, Abdullah Khalid, Todd Levy, Lyudmyla Demyan, Sarah Hartman, Elliot Newman, Matthew J. Weiss, Daniel A. King, Theodoros Zanos, Marcovalerio Melis. Machine learning to predict completion of treatment for pancreatic cancer. Journal of Surgical Oncology 2024; doi: 10.1002/jso.27812
|
| 28 |
Miguel A. Ortega, Oscar Fraile-Martinez, Leonel Pekarek, Cielo García-Montero, Miguel Angel Alvarez-Mon, Alejandro J. Castellanos, Natalio García-Honduvilla, Julia Buján, Melchor Alvarez-Mon, Miguel A. Sáez, Luis G. Guijarro, Angel Asúnsolo. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer. Antioxidants 2022; 11(4): 759 doi: 10.3390/antiox11040759
|
| 29 |
Hrvoje Kaučić, Domagoj Kosmina, Dragan Schwarz, Andreas Mack, Hrvoje Šobat, Adlan Čehobašić, Vanda Leipold, Iva Andrašek, Asmir Avdičević, Mihaela Mlinarić. Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study. Cancers 2022; 14(11): 2688 doi: 10.3390/cancers14112688
|
| 30 |
Kadir Çorbacı, Meryem Gunay Gurleyik, Aylin Gonultas, Fugen Aker, Mehmet Onur Gul, Metin Tilki. Evaluation of prognostic significance of histopathological characteristics and tumor-infiltrating lymphocytes for pancreatic cancer survival. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-79342-x
|
| 31 |
Xingren Guo, Xiangyang Song, Xiaoyin Long, Yahui Liu, Yixin Xie, Cheng Xie, Bai Ji. New nomogram for predicting lymph node positivity in pancreatic head cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1053375
|
| 32 |
Ali Tavakoli Pirzaman, Pouyan Ebrahimi, Shokat Niknezhad, Turan vahidi, Dariush Hosseinzadeh, Sousan Akrami, Arash M Ashrafi, Mohammad Moeen Velayatimehr, Rezvan Hosseinzadeh, Sohrab Kazemi. Toxic mechanisms of cadmium and exposure as a risk factor for oral and gastrointestinal carcinomas. Human & Experimental Toxicology 2023; 42 doi: 10.1177/09603271231210262
|
| 33 |
Sergio Pedrazzoli. Surgical treatment of pancreatic cancer: Currently debated topics on morbidity, mortality, and lymphadenectomy. Surgical Oncology 2022; 45: 101858 doi: 10.1016/j.suronc.2022.101858
|
| 34 |
Ao Liu, Hui Jiang, Weiwei Cao, Wenju Cui, Dehui Xiang, Chengwei Shao, Zhaobang Liu, Yun Bian, Jian Zheng. MLAGG-Net: Multi-level aggregation and global guidance network for pancreatic lesion segmentation in histopathological images. Biomedical Signal Processing and Control 2023; 86: 105303 doi: 10.1016/j.bspc.2023.105303
|
| 35 |
Kévin Toussaint, Aline Appert-Collin, Hamid Morjani, Camille Albrecht, Hervé Sartelet, Béatrice Romier-Crouzet, Pascal Maurice, Laurent Duca, Sébastien Blaise, Amar Bennasroune. Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases. Cancers 2022; 14(19): 4868 doi: 10.3390/cancers14194868
|
| 36 |
Miaoyan Wei, Rujiao Liu, Yunyun Xu, Xiaobing Chen, Chao Liu, Xueli Bai, Xiaochen Zhang, Shuiping Gao, Jialin Li, Zhen Sheng, Jianpo Lian, Wenliang Wang, Jian Zhang, Si Shi, Jin Xu, Xianjun Yu. Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03581-y
|
| 37 |
Tommaso Schepis, Sara Sofia De Lucia, Antonio Pellegrino, Angelo del Gaudio, Rossella Maresca, Gaetano Coppola, Michele Francesco Chiappetta, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli, Enrico Celestino Nista. State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. Cancers 2023; 15(13): 3423 doi: 10.3390/cancers15133423
|
| 38 |
Gabriela Rahnea-Nita, Laura-Florentina Rebegea, Valentin Titus Grigorean, Ionuţ Simion Coman, Violeta Elena Coman, Iancu Emil Pleşea, Anwar Erchid, Costin George Florea, Mircea Liţescu, Roxana-Andreea Rahnea-Nita. Long-Term Survival in Metastatic Pancreatic Adenocarcinoma of Intestinal Type. Journal of Clinical Medicine 2024; 13(17): 5034 doi: 10.3390/jcm13175034
|
| 39 |
Simon Kuesters, Johanna Sundheimer, Uwe A. Wittel, Sophia Chikhladze, Stefan Fichtner-Feigl, Esther A. Biesel. Pancreatic head resection for carcinoma of the ampulla vateri – better long-term prognosis, but more postoperative complications. Langenbeck's Archives of Surgery 2024; 409(1) doi: 10.1007/s00423-024-03319-7
|
| 40 |
Niccolò Surci, Christiane Rösch, Patrick Kirchweger, Lukas Havranek, Paul von Boetticher, Ines Fischer, Helwig Wundsam, Matthias Biebl, Reinhold Függer. The Rate of Avoidable Pancreatic Resections at a High-Volume Center: An Internal Quality Control and Critical Review. Journal of Clinical Medicine 2023; 12(4): 1625 doi: 10.3390/jcm12041625
|
| 41 |
Jiujie Cui, Shukui Qin, Yuhong Zhou, Shuang Zhang, Xiaofeng Sun, Mingjun Zhang, Jiuwei Cui, Weijia Fang, Kangsheng Gu, Zhihua Li, Jufeng Wang, Xiaobing Chen, Jun Yao, Jun Zhou, Gang Wang, Yuxian Bai, Juxiang Xiao, Wensheng Qiu, Bangmao Wang, Tao Xia, Chunyue Wang, Li Kong, Jiajun Yin, Tao Zhang, Xionghu Shen, Deliang Fu, Chuntao Gao, Huan Wang, Quanren Wang, Liwei Wang. Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01948-4
|
| 42 |
Lejun Gong, Dagui Gao, Xingxing Zhang, Shiqi Chen, Jiaqi Qian. REL-NPMI: Exploring genotype and phenotype relationship of pancreatitis based on improved normalized point-by-point mutual information. Computers in Biology and Medicine 2023; 158: 106868 doi: 10.1016/j.compbiomed.2023.106868
|
| 43 |
Prashant Kumar Tiwari, Poojhaa Shanmugam, Vamika Karn, Saurabh Gupta, Richa Mishra, Sarvesh Rustagi, Mandeep Chouhan, Devvret Verma, Niraj Kumar Jha, Sanjay Kumar. Extracellular Vesicular miRNA in Pancreatic Cancer: From Lab to Therapy. Cancers 2024; 16(12): 2179 doi: 10.3390/cancers16122179
|
| 44 |
Therapeutic Potential of lncRNAs in Regulating Disulfidptosis for Cancer Treatment. Pathology - Research and Practice 2024; 263: 155657 doi: 10.1016/j.prp.2024.155657
|
| 45 |
Igor E. Khatkov, Dmitry S. Bordin, Konstantin A. Lesko, Elena A. Dubtsova, Nikolay S. Karnaukhov, Maria A. Kiriukova, Nadezhda V. Makarenko, Alexey S. Dorofeev, Irina V. Savina, Diana A. Salimgereeva, Elena I. Shurygina, Ludmila V. Vinokurova. Contrast-Enhanced Computed Tomography and Laboratory Parameters as Non-Invasive Diagnostic Markers of Pancreatic Fibrosis. Diagnostics 2023; 13(14): 2435 doi: 10.3390/diagnostics13142435
|
| 46 |
Huijie Zhao, Huiyang Liu, Yihan Yang, Honggang Wang. The Emerging Role of EVA1A in Different Types of Cancers. International Journal of Molecular Sciences 2022; 23(12): 6665 doi: 10.3390/ijms23126665
|
| 47 |
Negin Riazi-Tabrizi, Mohammad Khalaj-Kondori, Sahar Safaei, Mohammad Amini, Hamidreza Hassanian, Mohadeseh Maghsoudi, Shima Hasani, Behzad Baradaran. NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel. Molecular Biotechnology 2024; 66(9): 2441 doi: 10.1007/s12033-023-00872-2
|
| 48 |
Karishma Kailass, Dominick Casalena, Lina Jenane, Gregor McEdwards, Douglas S. Auld, Oleg Sadovski, Esther G. Kaye, Elyse Hudson, David Nettleton, Mark A. Currie, Andrew A. Beharry. Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation. Journal of Medicinal Chemistry 2024; 67(3): 2019 doi: 10.1021/acs.jmedchem.3c01850
|
| 49 |
Yoshiyuki Meguro, Hironori Yamaguchi, Hideki Sasanuma, Kentaro Shimodaira, Yuichi Aoki, Takashi Chinen, Kazue Morishima, Hideyo Miyato, Atsushi Miki, Kazuhiro Endo, Alan Kawarai Lefor, Joji Kitayama, Naohiro Sata. Combined Intraperitoneal Paclitaxel and Systemic Chemotherapy for Patients with Massive Malignant Ascites Secondary to Pancreatic Cancer: A Report of Two Patients. Internal Medicine 2024; 63(14): 2015 doi: 10.2169/internalmedicine.2191-23
|
| 50 |
Jagoda Oliwia Rogowska, Łukasz Durko, Ewa Malecka-Wojciesko. The Latest Advancements in Diagnostic Role of Endosonography of Pancreatic Lesions. Journal of Clinical Medicine 2023; 12(14): 4630 doi: 10.3390/jcm12144630
|
| 51 |
Cosimo Sperti, Simone Serafini, Alberto Friziero, Matteo Todisco, Giulia Tamponi, Domenico Bassi, Amanda Belluzzi. Extended Distal Pancreatectomy for Cancer of the Body and Tail of the Pancreas: Analysis of Early and Late Results. Journal of Clinical Medicine 2023; 12(18): 5858 doi: 10.3390/jcm12185858
|
| 52 |
Silvius Negoita, Romeo Ionescu, Monica Zlati, Valentin Antohi, Alexandru Nechifor. New Regional Dynamic Cancer Model across the European Union. Cancers 2023; 15(9): 2545 doi: 10.3390/cancers15092545
|
| 53 |
Bohan Yang, Kai Chen, Weikang Liu, Di Long, Yingjin Wang, Xinxin Liu, Yongsu Ma, Xiaodong Tian, Yinmo Yang. The benefits of neoadjuvant therapy for patients with resectable pancreatic cancer: an updated systematic review and meta-analysis. Clinical and Experimental Medicine 2023; 23(7): 3159 doi: 10.1007/s10238-023-01112-2
|
| 54 |
Jinping Zhang, Shuman Zhang, Isabella Dörflein, Xiaofan Ren, Susanne Pfeffer, Nathalie Britzen-Laurent, Robert Grützmann, Xianglong Duan, Christian Pilarsky. Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer. Cancers 2023; 15(19): 4842 doi: 10.3390/cancers15194842
|
| 55 |
Gang Ma, Zhangyu Guo, Xiao Zhang, Huamei Zhang, Yang Wang, Jianchun Li, Yang Yuan, Jin Zhou. Carboxylesterase-mediated imaging tool for diagnosis of liver injury and surgical resection navigation of pancreatic cancer. Sensors and Actuators B: Chemical 2024; 411: 135738 doi: 10.1016/j.snb.2024.135738
|
| 56 |
Yi Chen, Liu-Yan Li, Jian-Di Li, Rong-Quan He, Zhi-Guang Huang, Wan-Ying Huang, Jia-Yuan Luo, Yi-Wu Dang, Gang Chen, Dan-Ming Wei. Expression, potential biological behaviour and clinical significance of MCM3 in pancreatic adenocarcinoma: a comprehensive study integrating high throughput sequencing, CRISPR screening and in-house immunohistochemistry. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2405879
|
| 57 |
Liwen Fan, Xinyu Wang, Qing Chang, Yue Wang, Wenjie Yang, Linlin Liu. IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma. Medicine 2022; 101(42): e30966 doi: 10.1097/MD.0000000000030966
|
| 58 |
Yonghao Ouyang, Rongxi Shen, Lihua Chu, Chengchao Fu, Wang Hu, Haoxuan Huang, Zhicheng Zhang, Ming Jiang, Xin Chen. Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-65917-1
|
| 59 |
Taichi Terai, Satoshi Nishiwada, Minako Nagai, Kota Nakamura, Yuichiro Kohara, Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, Takeshi Sakata, Hirokimi Kumada, Mizuki Watanabe, Masayuki Sho. Clinical impact of carbonic anhydrase 9 expression on neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Pancreatology 2024; 24(6): 938 doi: 10.1016/j.pan.2024.08.003
|
| 60 |
Eva Thoma, Thilo Hackert, Christoph W. Michalski, Felix J. Hüttner. The Pancreas. 2023; : 1117 doi: 10.1002/9781119876007.ch144
|
| 61 |
Zhou-Yan Jia, Xin Yan, Hao Zhou, Wei Wang, Chen Li, Bang-Le Zhang. Anti-PD-L1 checkpoint inhibitor combined with nanocarrier-mediated cisplatin codelivery system for effective treatment of pancreatic cancer. Molecular Immunology 2024; 174: 69 doi: 10.1016/j.molimm.2024.08.006
|
| 62 |
Magdalena Boćkowska, Przemysław Kostro, Zbigniew Kamocki. Phase Angle and Postoperative Complications in a Model of Immunonutrition in Patients with Pancreatic Cancer. Nutrients 2023; 15(20): 4328 doi: 10.3390/nu15204328
|
| 63 |
Yasuharu Kawamoto, Kenji Ikezawa, Takahiro Tabuchi, Toshitaka Morishima, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Sena Higashi, Makiko Urabe, Yugo Kai, Ryoji Takada, Takuo Yamai, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Isao Miyashiro, Kazuyoshi Ohkawa. Hospital volume and prognosis of patients with metastatic pancreatic cancer: A study using the Osaka Cancer Registry. Journal of Cancer Research and Clinical Oncology 2023; 149(14): 12835 doi: 10.1007/s00432-023-04966-x
|
| 64 |
Weixuan Liu, Bairui Zhang, Tao Liu, Juntao Jiang, Yong Liu. Artificial Intelligence in Pancreatic Image Analysis: A Review. Sensors 2024; 24(14): 4749 doi: 10.3390/s24144749
|
| 65 |
Songbai Liu, Peng Liu, Xiaobin Fei, Changhao Zhu, Junyi Hou, Xing Wang, Yaozhen Pan. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach. Oncology Letters 2023; 26(1) doi: 10.3892/ol.2023.13871
|
| 66 |
Basil N Nduma, Solomon Ambe, Chukwuyem Ekhator, Ekokobe Fonkem. Geographical Distribution of Pancreatic Cancer in the State of Mississippi by Incidence and Mortality From 2003 to 2019. Cureus 2022; doi: 10.7759/cureus.31605
|
| 67 |
Wei Liu, Dongwei Hu, Jinjie Li, Qigang Xu, Zongjing Chen, Bo Xu. CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2216041
|
| 68 |
Ying Liu, Babatunde O. Okesola, David Osuna de la Peña, Weiqi Li, Meng‐Lay Lin, Sara Trabulo, Marianthi Tatari, Rita T. Lawlor, Aldo Scarpa, Wen Wang, Martin Knight, Daniela Loessner, Christopher Heeschen, Alvaro Mata, Oliver M. T. Pearce. A Self‐Assembled 3D Model Demonstrates How Stiffness Educates Tumor Cell Phenotypes and Therapy Resistance in Pancreatic Cancer. Advanced Healthcare Materials 2024; 13(17) doi: 10.1002/adhm.202301941
|
| 69 |
Philip Salu, Katie M. Reindl. Advancements in Preclinical Models of Pancreatic Cancer. Pancreas 2024; 53(2): e205 doi: 10.1097/MPA.0000000000002277
|
| 70 |
Raoof Nopour. Establishment of prediction model for mortality risk of pancreatic cancer: a retrospective study. BMC Medical Informatics and Decision Making 2024; 24(1) doi: 10.1186/s12911-024-02590-4
|
| 71 |
Shanshi Tong, Zhilong Yu, Fang Yin, Qilin Yang, Juhang Chu, Luyao Huang, Wenxue Gao, Mingping Qian. Manganese-based Prussian blue nanoparticles inhibit tumor proliferation and migration via the MAPK pathway in pancreatic cancer. Frontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.1026924
|
| 72 |
Yang Li, Kai-di Yang, Hao-yu Duan, Ya-nan Du, Jun-feng Ye. Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1231503
|
| 73 |
Ya-Fei Hu, Hai-Jie Hu, Heng-Chung Kung, Tian-Run Lv, Jun Yu, Fu-Yu Li. DNA damage repair mutations in pancreatic cancer– prognostic or predictive?. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1267577
|
| 74 |
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Puolakkainen, Sakari Knuutila. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. Biomolecules 2022; 12(5): 652 doi: 10.3390/biom12050652
|
| 75 |
Keiji Nagata, Masatoshi Kajiwara, Takahisa Fujikawa. Long-Term Survival of a Patient With Peritoneal Carcinomatosis From Pancreatic Cancer Maintained by Nanoliposomal Irinotecan as Third-Line Chemotherapy. Cureus 2022; doi: 10.7759/cureus.22355
|
| 76 |
Mohammed Hikmat Faeq, Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Farshad gharebakhshi, Faroogh Marofi, Safa Tahmasebi, Shadan Modaresahmadi. CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical Oncology 2023; 40(5) doi: 10.1007/s12032-023-02019-4
|
| 77 |
Albert W. Girotti, Jerzy Bazak, Witold Korytowski. Pro-Tumor Activity of Endogenous Nitric Oxide in Anti-Tumor Photodynamic Therapy: Recently Recognized Bystander Effects. International Journal of Molecular Sciences 2023; 24(14): 11559 doi: 10.3390/ijms241411559
|
| 78 |
Bingyan Liu, Yongjun Gong, Qiyi Jiang, Shaoqiu Wu, Bo Han, Feier Chen, Quanjun Lin, Ping Wang, Dengke Yang. Hsa_circ_0014784-induced YAP1 promoted the progression of pancreatic cancer by sponging miR-214-3p. Cell Cycle 2023; 22(13): 1583 doi: 10.1080/15384101.2023.2222519
|